Literature DB >> 15354865

The role of PrP in health and disease.

E Flechsig1, C Weissmann.   

Abstract

Transmissible spongiform encephalopathies (TSEs) such as scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle or Creutzfeldt-Jacob disease (CJD) and Gerstmann-Sträussler-Scheinker syndrome (GSS) in humans, are caused by an infectious agent designated prion. The "protein only" hypothesis states that the prion consists partly or entirely of a conformational isoform of the normal host protein PrPc and that the abnormal conformer, when introduced into the organism, causes the conversion of PrPc into a likeness of itself. Since the proposal of the "protein only" hypothesis more than three decades ago, cloning of the PrP gene, studies on PrP knockout mice and on mice transgenic for mutant PrP genes allowed deep insights into prion biology. Reverse genetics on PrP knockout mice containing modified PrP transgenes was used to address a variety of problems: mapping PrP regions required for prion replication, studying PrP mutations affecting the species barrier, modeling familial forms of human prion disease, analysing the cell specificity of prion propagation and investigating the physiological role of PrP by structure-function studies. Many questions regarding the role of PrP in susceptibility to prions have been elucidated, however the physiological role of PrP and the pathological mechanisms of neurodegeneration in prion diseases are still elusive.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15354865     DOI: 10.2174/1566524043360645

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  15 in total

1.  Lethal recessive myelin toxicity of prion protein lacking its central domain.

Authors:  Frank Baumann; Markus Tolnay; Christine Brabeck; Jens Pahnke; Ulrich Kloz; Hartmut H Niemann; Mathias Heikenwalder; Thomas Rülicke; Alexander Bürkle; Adriano Aguzzi
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

Review 2.  The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.

Authors:  Konstanze F Winklhofer; Jörg Tatzelt; Christian Haass
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

3.  Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.

Authors:  Hideyuki Hara; Yuko Okemoto-Nakamura; Fumiko Shinkai-Ouchi; Kentaro Hanada; Yoshio Yamakawa; Ken'ichi Hagiwara
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

Review 4.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

5.  Knockout of the prion protein (PrP)-like Sprn gene does not produce embryonic lethality in combination with PrP(C)-deficiency.

Authors:  Nathalie Daude; Serene Wohlgemuth; Rebecca Brown; Rose Pitstick; Hristina Gapeshina; Jing Yang; George A Carlson; David Westaway
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-22       Impact factor: 11.205

Review 6.  Copper and the prion protein: methods, structures, function, and disease.

Authors:  Glenn L Millhauser
Journal:  Annu Rev Phys Chem       Date:  2007       Impact factor: 12.703

Review 7.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

8.  Ultramicroscopy reveals axonal transport impairments in cortical motor neurons at prion disease.

Authors:  Vladimir Ermolayev; Mike Friedrich; Revaz Nozadze; Toni Cathomen; Michael A Klein; Gregory S Harms; Eckhard Flechsig
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

9.  Mammalian amyloidogenic proteins promote prion nucleation in yeast.

Authors:  Pavithra Chandramowlishwaran; Meng Sun; Kristin L Casey; Andrey V Romanyuk; Anastasiya V Grizel; Julia V Sopova; Aleksandr A Rubel; Carmen Nussbaum-Krammer; Ina M Vorberg; Yury O Chernoff
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

10.  Impaired axonal transport in motor neurons correlates with clinical prion disease.

Authors:  Vladimir Ermolayev; Toni Cathomen; Julia Merk; Mike Friedrich; Wolfgang Härtig; Gregory S Harms; Michael A Klein; Eckhard Flechsig
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.